Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Michael R. Dougherty | Director | 2023-01-11 | 33,523 | $0.44 | $14.75kBuy |
John J. Kirby | CHIEF FINANCIAL OFFICER | 2023-01-06 | 119,957 | $0.71 | $85.17kSell |
Bryant David Lim | SVP AND GENERAL COUNSEL | 2023-01-06 | 119,957 | $0.71 | $85.17kSell |
Andrew R. Jordan | CHIEF STRATEGY OFFICER | 2023-01-06 | 73,940 | $0.71 | $52.50kSell |
Michael R. Dougherty | Director | 2022-10-03 | 58,516 | $0.38 | $21.94kBuy |
Pillar Invest Corp | 10% Owner | 2022-09-22 | 1,533,159 | $0.01 | $15.33kBuy |
Michael R. Dougherty | Director | 2022-07-01 | 50,086 | $0.44 | $21.94kBuy |
Michael R. Dougherty | Director | 2022-04-01 | 41,155 | $0.54 | $22.02kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Pillar Invest Corp | 843.62% | 30,943,672 | $92.83M | Insider |
Pillar Pharmaceuticals I LP | 371.50% | 13,626,469 | $40.88M | Insider |
Senator Investment Group LP | 239.23% | 8,774,905 | $26.32M | Insider |
Baker Biotech Capital GP LLC | 158.11% | 5,799,598 | $17.40M | Insider |
Baker Biotech Capital Ii GP LLC | 138.90% | 5,094,924 | $15.28M | Insider |
Baker Brothers Life Sciences Capital GP LLC | 136.69% | 5,013,762 | $15.04M | Insider |
Baker Bros Advisors LP | 121.23% | 4,446,590 | $13.34M | Insider |
Pillar Pharmaceuticals Iii LP | 70.88% | 2,600,000 | $7.80M | Insider |
Youssef El Zein | 43.41% | 1,592,092 | $4.78M | Insider |
John Clayton Taylor | 40.06% | 1,469,482 | $4.41M | Insider |